Viewing Study NCT03830918


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-02-22 @ 2:37 AM
Study NCT ID: NCT03830918
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-14
First Post: 2019-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
Sponsor:
Organization: